BC
BioCardia, Inc.
BCDA · NASDAQ
$1.11 -1.33% (-$0.02)
1M +10.92%
Market Cap $16.4M
P/E Ratio -
Div. Yield -
ROE 569.36%
Piotroski F-Score Weak
1/9Valuation
24 /100
Expensive P/B 6.06x
PEG N/A
P/E N/A
Growth
0 /100
Declining Book val. growth 43.23%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 154.34%
ROIC 246.91%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 2.09x
Debt/Equity 0.11x
Debt/Assets N/A
Stability
60 /100
Moderate EPS volatility 24.83%
Beta 0.49x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre BCDA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Peter A. Altman
Employees
17
Headquarters
Sunnyvale
Evenimente viitoare
11 NOV.
Earnings
Upcoming earnings report